XML 23 R9.htm IDEA: XBRL DOCUMENT v3.22.1
Shareholders' Deficit
 3 Months Ended
Mar. 31, 2022
Stockholders' Equity Note [Abstract]  
Shareholders' Equity Shareholders' Deficit
Under the authority of our Board of Directors, we repurchased shares of our Common Stock during the quarters ended March 31, 2022 and 2021 as indicated below.  All amounts exclude applicable transaction fees. 

 Shares Repurchased
(thousands)		Dollar Value of Shares
Repurchased		Remaining Dollar Value of Shares that may be Repurchased
Authorization Date20222021202220212022
November 2019— 

2,599 $— 

$275 $— 
May 20213,359 — 407 — 543 
Total3,359 
(a)
2,599 
(b)
$407 
(a)
$275 
(b)
$543 

(a)    2022 amount includes the effect of $64 million in share repurchases (0.5 million shares) with trade dates on, or prior to, March 31, 2022, but cash settlement dates subsequent to March 31, 2022.

(b)    2021 amount excludes the effect of $11 million in share repurchases (0.1 million shares) with trade dates on, or prior to December 31, 2020, but cash settlement dates subsequent to December 31, 2020.

In May 2021, our Board of Directors authorized share repurchases from July 1, 2021 through December 31, 2022, of up to $2 billion (excluding applicable transaction fees) of our outstanding Common Stock.
Changes in Accumulated other comprehensive loss (“AOCI”) are presented below.
Translation Adjustments and Gains (Losses) From Intra-Entity Transactions of a Long-Term NaturePension and Post-Retirement BenefitsDerivative InstrumentsTotal
Balance at December 31, 2021, net of tax$(206)$(34)$(85)$(325)
OCI, net of tax
Gains (losses) arising during the period classified into AOCI, net of tax
(23)— 43 20 
(Gains) losses reclassified from AOCI, net of tax
— 4 9 13 
(23)4 52 33 
Balance at March 31, 2022, net of tax$(229)$(30)$(33)$(292)